Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by Sandpointon Jun 19, 2020 11:57am
184 Views
Post# 31169682

BLA date is no longer H1 2020

BLA date is no longer H1 2020The latest presentation had this quote dealing with dates for milestones:

"As a result of these necessary and appropriate steps, we are no longer able to provide detailed guidance on the timing of many key milestones for our business."

The BLA application milestone in the presentation no longer has a date associated with it.  It seems that with a week and a half until  the end of H1 2020 (July 1), they would know if they were going to meet the H1 target, and put a date on the milestone. But no date. 
As a resultof thesenecessaryand appropriatesteps, weare no longer able to providedetailedguidance on the timing of manykey milestonesfor ourbusiness.
As a resultof thesenecessaryand appropriatesteps, weare no longer able to providedetailedguidance on the timing of manykey milestonesfor ourbusiness.
<< Previous
Bullboard Posts
Next >>